# BUDESONIDE
> **ANDA206724** · Abbreviated New Drug Application (Generic) · Sponsor: NATCO · Approved 2016-11-23
## Drug
- **FDA Application Number:** ANDA206724
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BUDESONIDE
- **Generic name:** Budesonide
- **Active ingredients:** BUDESONIDE
- **Dosage form:** CAPSULE, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** NATCO
- **First approval:** 2016-11-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206724)
---
*MORVS · CC0 1.0*